Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-07-04T16:58:38.925Z Has data issue: false hasContentIssue false

Fabry’s Disease Presenting as Stroke in a Young Female

Published online by Cambridge University Press:  02 December 2014

Paul S. Giacomini
Affiliation:
McGill University Health Center, Department of Neurology and Neurosurgery, Montreal, Quebec
Patrick T. Shannon
Affiliation:
Department of Neuropathology, University of Toronto School of Medicine, Toronto, Ontario, Canada
Joe T.R. Clarke
Affiliation:
Department of Pediatrics, University of Toronto School of Medicine, Toronto, Ontario, Canada
Cheryl Jaigobin
Affiliation:
Department of Neurology, University of Toronto School of Medicine, Toronto, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Fabry’s disease is an X-linked disorder, caused by a deficiency of the lysosomal enzyme α-galactosidase A which results in the accumulation of the glycosphingolipid, ceramide trihexose in the vascular endothelium and can lead to cerebral infarction. Male hemizygotes are generally more severely affected than heterozygote females. Clinical disease in females is thought to be due to unequal X chromosome inactivation.

Case:

A 19-year-old woman, who was previously well, presented with neurological deficits secondary to basal ganglia and pontine infarction. Extensive cardiac, arterial and hematologic investigations did not identify the etiology of her stroke. Muscle biopsy revealed endothelial lysosomal aggregates most consistent with a diagnosis of Fabry’s disease. The diagnosis was confirmed on the basis of molecular genotype analysis.

Discussion:

Inherited causes of stroke such as Fabry’s disease should be considered in young patients with stroke if an etiologic diagnosis is not reached after complete investigations. Muscle biopsy can assist with the diagnosis and guide further investigations. This report summarizes the biochemical and histological features of Fabry’s disease and the associated genetic abnormalities.

Type
Case Report
Copyright
Copyright © The Canadian Journal of Neurological 2004

References

1.Desnick, RJ, Ioannou, YA, Eng, CH.Alpha galactosidase Adeficiency: Fabry disease. In: Scriver, CR, Beaudet, AL, Sly, WS, Valle, D (Eds). The Metabolic & Molecular Bases of Inherited Disease. 8th ed.McGraw Hill 2001: 37333774.Google Scholar
2.Elleder, M, Ledvinova, J, Vosmik, F, et al.An atypical ultrastructuralpattern in Fabry’s disease: a study on its nature and incidence in 7 cases. Ultrastruct Pathol 1990; 14:467474.Google Scholar
3.Bird, TD, Lagunoff, D.Neurological manifestations of Fabry diseasein female carriers. Ann Neurol 1978; 4: 537540.CrossRefGoogle Scholar
4.Hozumi, I, Nishizawa, M, Ariga, T, et al.Accumulation ofglycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry disease. J Neurol Sci 1989;90: 273280.CrossRefGoogle Scholar
5.Ropers, HH, Wienker, TF, Grimm, T, Schroetter, K, Bender, K.Evidence for preferential X-chromosome inactivation in a familywith Fabry disease. Am J Hum Genet 1977; 29: 361370.Google Scholar
6.Bradley, J, Boden-Abala, B, Lin, I-F, Sacco, R.Stroke in the young inthe Northern Manhattan Stroke Study. Stroke 2002; 27892793.Google Scholar
7.Adams, HP Jr, Kappelle, LJ, Biller, J, et al.Ischemic stroke in youngadults. Experience in 329 patients enrolled in the Iowa registry of stroke in young adults. Arch Neurol 1995; 52: 491495.Google Scholar
8.Bogousslavsky, J, Regli, F.Ischemic stroke in adults younger than 30years of age. Arch Neurol 1987; 44: 479482.CrossRefGoogle Scholar
9.Kittner, SJ, Stern, BJ, Wozniak, M, et al. Cerebral infarction in youngadults: the Baltimore-Washington Cooperative Young StrokeStudy. Neurology 1998; 50: 890894.Google Scholar
10.Mitsias, P, Levine, S.Cerebrovascular complications of Fabry’sdisease. Ann Neurol 1996; 40: 817.Google Scholar